Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Barfresh Food Group Q1 2026 Earnings Call - Revenue Surges on Arps Dairy Acquisition, but Margins Lag as Management Targets Low-40s Gross Margin by Year-End
Barfresh Food Group delivered a strong top-line beat in Q1 2026, with revenue jumping 92% year-over-year to $5.6 million, driven largely by the newly acquired Arps Dairy business. However, the acquisi...
- Q1 2026 revenue reached $5.6 million, a 92% year-over-year increase driven by the Arps Dairy acquisition, beating the high end of the $5.0 million to $5.2 million guidance range.
- Gross margin contracted to 18% from 31% in Q1 2025 due to the lower-margin Arps Dairy milk processing business and transition costs at the new Defiance, Ohio facility.
- Adjusted EBITDA loss narrowed to approximately $238,000 from $506,000 in the prior year period, though it missed breakeven guidance due to revenue mix and startup inefficiencies.
- +7 more takeaways
P3 Health Partners Q1 2026 Earnings Call - Flat Medical Trend Drives EBITDA Beat and Raised Outlook
P3 Health Partners delivered a strong Q1 2026, generating $26 million in adjusted EBITDA and beating internal expectations, driven by structural contract redesign, disciplined clinical execution, and ...
- Q1 2026 adjusted EBITDA of $26 million exceeded internal expectations, marking a significant turnaround from a $22 million loss in Q1 2025.
- Medicare Advantage medical cost trend remained roughly flat in Q1 2026, defying industry-wide guidance of 7% or higher, driven by tier-1 provider concentration and disciplined utilization management.
- Per-member funding for the Medicare Advantage population improved approximately 15% year-over-year, reflecting rate progression, contractual restructuring, and enhanced burden-of-illness documentation.
- +7 more takeaways
XTI Aerospace Q1 2026 Earnings Call - Drone Nerds Drives Margin Expansion and Cash Flow Inflection
XTI Aerospace’s first quarter 2026 results mark a turning point. The company, now fully integrated with its acquisition of Drone Nerds, is shifting from a legacy design and development model to a reve...
- Full-year 2026 revenue guidance stands at approximately $160 million or greater, with projected gross margins of 19-21% and EBITDA margins of 9-10%.
- XTI Aerospace is transitioning from a legacy design and development business to a revenue-generating unmanned systems platform centered on Drone Nerds.
- First quarter 2026 marks the first full quarter of Drone Nerds’ operating performance in consolidated results, showing meaningful progress in cost reduction and cash burn improvement.
- +7 more takeaways
RideNow Q1 2026 Earnings Call - EBITDA Surges 33% as Turnaround Accelerates
RideNow delivered a strong first quarter, with revenue rising 6.4% to $260.4 million and adjusted EBITDA jumping 32.9% to $9.3 million. The company marked its fourth consecutive quarter of year-over-y...
- Total revenue reached $260.4 million, up 6.4% year-over-year, driven by higher sales of new and pre-owned retail vehicles.
- Adjusted EBITDA grew 32.9% to $9.3 million, marking the fourth consecutive quarter of year-over-year improvement.
- Same-store unit sales increased 16.3% and same-store revenue rose 13.1%, reflecting sustained demand across the store network.
- +7 more takeaways
Jones Soda Co. Q1 2026 Earnings Call - Fallout Collabs Drive 194% Revenue Surge to $12.4M, First GAAP Profitability Achieved
Jones Soda delivered a staggering 194% year-over-year revenue jump to $12.4 million in Q1 2026, powered by an unexpected win with the Fallout franchise in club stores and a disciplined push into mains...
- Revenue surged 194% year-over-year to $12.4 million in Q1 2026, significantly beating management guidance and driven primarily by Fallout branded products in the club channel.
- The company achieved its first GAAP net income profitability since the new leadership team took over, posting $115,000 in net income compared to an $852,000 loss in the prior year period.
- Adjusted EBITDA turned positive at $0.6 million, marking the second consecutive quarter of profitability and validating the operational improvements implemented over the past year.
- +10 more takeaways
Dragonfly Energy Q1 2025 Earnings Call - Stevens Transport Lands $3M Heavy-Duty Order
Dragonfly Energy reported Q1 2025 results that beat top-line guidance, though the broader RV market remains soft. The real story is the commercial inflection in heavy-duty trucking. Stevens Transport,...
- Dragonfly Energy reported Q1 2025 net sales of $9.7 million, beating guidance, driven by $5.8 million in OEM revenue and $3.7 million in DTC sales.
- Stevens Transport placed a landmark $3 million purchase order for nearly 500 trucks, covering Dragonfly's full heavy-duty trucking product portfolio including the DualFlow Power Pack and All-Electric APU.
- The Stevens order represents a critical inflection point, transitioning Dragonfly from pilot deployments to fleet-wide commercial adoption in the heavy-duty trucking sector.
- +7 more takeaways
CV Sciences Q1 2026 Earnings Call - Near Cash Flow Breakeven as Company Pivots Beyond CBD
CV Sciences reported Q1 2026 revenue of $3.2 million, a modest 3% sequential decline, but the real story lies in the margin expansion and cost discipline. Gross margins held at 48.9% despite rising in...
- Revenue of $3.2 million in Q1 2026, down 3% sequentially and 11% year-over-year, driven by a 12% decline in unit sales.
- Gross margin held steady at 48.9%, up from 46.0% in Q1 2025, supported by lower product costs and insourcing manufacturing.
- Operating expenses dropped 13.3% year-over-year to $1.9 million, reflecting structural cost reductions in legal, marketing, and admin.
- +9 more takeaways
Sangamo Therapeutics Q1 2026 Earnings Call - FDA Clears Path for Accelerated Fabry Approval Without Confirmatory Trial
Sangamo Therapeutics advanced its rolling BLA submission for ST-920 in Fabry disease, with the FDA confirming that a confirmatory trial is unnecessary and that 104-week data can serve as traditional a...
- Rolling BLA submission for ST-920 in Fabry disease is underway, with the first two modules already filed and the CMC module in progress. The company targets a complete submission by summer, contingent on securing additional funding.
- The FDA recently reaffirmed that ST-920 can receive accelerated approval based on mean annualized eGFR slope at 52 weeks across all 32 dosed patients, and a confirmatory trial is not required for traditional approval.
- 104-week data from all patients will be submitted when seeking traditional approval, with the last patient reaching the 2-year milestone in April and data analysis currently in progress.
- +7 more takeaways
Newsmax Q1 2026 Earnings Call - Affiliate Fees and International Licensing Drive Revenue Growth Amidst Streaming Expansion
Newsmax delivered a strong start to 2026 with Q1 2026 revenue of $51.7 million, up 14% year-over-year, driven by a 20.8% surge in broadcasting revenue fueled by affiliate fee growth and international ...
- Total revenue reached $51.7 million, up 14% year-over-year, with broadcasting revenue surging 20.8% to $43.7 million.
- Affiliate fee revenue jumped 75.2% year-over-year to $13 million, driven by new contractual relationships and rate increases from late 2025.
- Digital advertising revenue declined 12.7% to $8 million, reflecting a tougher comparison after the elevated demand of the 2024 election cycle.
- +7 more takeaways
Vuzix Corporation Q1 2026 Earnings Call - OEM and Waveguide Momentum Builds Despite Revenue Dip
Vuzix reported Q1 2026 revenue of $1.4 million, down 12% year-over-year, driven by lower M400 unit sales. However, the company signaled accelerating momentum in its two core growth engines: OEM smart ...
- Total revenue fell 12% year-over-year to $1.4 million, dragged by lower M400 smart glasses sales.
- Engineering services revenue climbed 36% to $0.35 million, signaling growing customer-funded development work.
- Gross loss widened to $0.4 million from $0.3 million as fixed manufacturing costs were less absorbed by lower sales.
- +7 more takeaways